Clinical Manifestations and Pathogenesis of Acute Necrotizing Encephalopathy: The Interface Between Systemic Infection and Neurologic Injury
Authors:
Open Access
- 4 January 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 12, 628811
Abstract
Acute necrotizing encephalopathy (ANE) is a devastating neurologic condition that can arise following a variety of systemic infections, including influenza and SARS-CoV-2. Affected individuals typically present with rapid changes in consciousness, focal neurological deficits, and seizures. Neuroimaging reveals symmetric, bilateral deep gray matter lesions, often involving the thalami, with evidence of necrosis and/or hemorrhage. The clinical and radiologic picture must be distinguished from direct infection of the central nervous system by some viruses, and from metabolic and mitochondrial disorders. Outcomes following ANE are poor overall and worse in those with brainstem involvement. Specific management is often directed toward modulating immune responses given the potential role of systemic inflammation and cytokine storm in potentiating neurologic injury in ANE, though benefits of such approaches remain unclear. The finding that many patients have mutations in the nucleoporin gene RANBP2, which encodes a multifunctional protein that plays a key role in nucleocytoplasmic transport, may allow for the development of disease models that provide insights into pathogenic mechanisms and novel therapeutic approaches.Keywords
This publication has 120 references indexed in Scilit:
- The Oncogene eIF4E Reprograms the Nuclear Pore Complex to Promote mRNA Export and Oncogenic TransformationCell Reports, 2012
- Cytokines and brain excitabilityFrontiers in Neuroendocrinology, 2012
- The Nucleoporin Nup358/RanBP2 Promotes Nuclear Import in a Cargo‐ and Transport Receptor‐Specific MannerTraffic, 2011
- Ran-dependent docking of importin-β to RanBP2/Nup358 filaments is essential for protein import and cell viabilityJournal of Cell Biology, 2011
- A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathyBrain, 2011
- Protein targets of inflammatory serine proteases and cardiovascular diseaseJournal of Inflammation, 2010
- Infection-Triggered Familial or Recurrent Cases of Acute Necrotizing Encephalopathy Caused by Mutations in a Component of the Nuclear Pore, RANBP2The American Journal of Human Genetics, 2009
- The Nup358-RanGAP Complex Is Required for Efficient Importin α/β-dependent Nuclear ImportMolecular Biology of the Cell, 2008
- RanBP2 Modulates Cox11 and Hexokinase I Activities and Haploinsufficiency of RanBP2 Causes Deficits in Glucose MetabolismPLOS Genetics, 2006
- Nup214 Is Required for CRM1-Dependent Nuclear Protein Export In VivoMolecular and Cellular Biology, 2006